Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 102084
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.102084
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.102084
Figure 8 Role of RORA in hepatocellular carcinoma as a downstream gene for MEX3A.
A-C: Real-time fluorescent quantitative PCR and western blotting detection of the knockdown efficiency of MEX3A and RORA; D: Cell counting kit-8 assay detection of the proliferative ability of the cells divided into four groups of HepG2 cells (“c”represents significant difference between the shNC + siNC and shMEX3A + siNC groups; “d” represents significant difference between the shMEX3A + siRORA and shMEX3A + siNC groups); E and F: Crystal violet staining was used to detect the clone formation ability of the cells divided into four groups; G and H: Western blotting detection of the effect of MEX3A or RORA silencing on expression of proteins in the Wnt/-catenin pathway. Data are presented as the mean ± SD; I: Immunofluorescence was used to detect the accumulation of β-catenin in the nucleus. aP < 0.05, bP < 0.01, cP < 0.001, dP < 0.001. Scale bar = 50 μm.
- Citation: Ji PX, Zhang P, Zhou HL, Yu H, Fu Y. MEX3A promotes cell proliferation by regulating the RORA/β-catenin pathway in hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(4): 102084
- URL: https://www.wjgnet.com/1948-5204/full/v17/i4/102084.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i4.102084